OPDIVO is a prescription medicine used in combination with YERVOY as a first treatment to treat adults with cancer of the ...

The trial met its primary endpoint, demonstrating a statistically significant 77% proptosis response rate at 24 weeks.

Two Alzheimer's drugs were hailed as treatments that would transform care. Why are barely any UK patients getting them?

Primary and Key Secondary Endpoints Met 77% of Patients Achieved Highly Statistically Significant Proptosis Response Study Showed Clinically Meaningful Reduction ...

The findings could help Amgen defend Tepezza’s market-leading position against emerging rivals, though some analysts ...

Under the agreement, Vertex will make a $15m upfront payment to Halozyme and potential future milestone payments.

As drugmakers strive to fine tune the delivery of their medications for better convenience and patient adherence, Halozyme is putting a recent acquisition in the space to work, thanks to a new tie- | ...

Drugmakers Novo Nordisk and Eli Lilly and Company have transformed the landscape of chronic weight loss management with the ...

Mineral casts of cancer cell surfaces reprogram fat cells into stem cells and improve insulin sensitivity in obese mice ...

Amgen's Tepezza became the first drug approved by the FDA for thyroid eye disease (TED) in 2020, and the company is now looking to extend its role with a new, more patient-friendly formulation. The ...

This new Aramchol formulation was co-developed by Galmed and Barcode Nanotech, based on Barcode Nanotech's unique and proprietary platform which enables simultaneous screening of hundreds of different ...

When does the circadian clock start ticking? A new study shows that fetal clocks synchronize to the mother in the womb via hormones, highlighting the importance of light and sleep during pregnancy.